국가연구개발과제 생명의학윤리 감독체계에 대한 인식조사 및 제언
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강영희 | - |
dc.contributor.author | 이상미 | - |
dc.contributor.author | 권광일 | - |
dc.contributor.author | 김은영 | - |
dc.contributor.author | 허우성 | - |
dc.date.available | 2019-03-08T23:42:04Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 1226-6051 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/13385 | - |
dc.description.abstract | Purpose: Aim of this study was to gather and evaluate perceptions of investigators, IRB members, and IRB administratorson the appropriateness of IRB review process and bioethical oversight system of national R&D (NR&D) projects. Method: Investigators, IRB members, and IRB administrators at 17 different institutions were surveyed using conveniencesampling and survey questionnaires were partially group-specialized to consider any differences between thegroups. Results: Participants included 29 investigators, 37 IRB members, and 17 administrators with response rate of100% (83 of 83). According to the responses obtained, insufficient preparation time for constructing protocol and gainingIRB approval was one of the main problems in the IRB review process (investigator 79.3%, IRB administrator88.2%). Also, discrepancy between NR&D and IRB’s protocol formats was another major issue (IRB members 96.4%,IRB administrator 100%) and most investigators (89.7%) had to modify the original NR&D protocol to obtain IRBapproval. Moreover, it was reported that 13.8% of investigators and 31.3% of IRB administrators did not submit midyearreports to IRB and for bioethical issues of NR&D projects, 17.2% of investigators did not include information onproject status and safety issues in the annual reports. Conclusion: In conclusion, for successful and ethical completionof R&D projects, revision of both IRB review process and NR&D project protocol formats as well as implementationof appropriate bioethical oversights are necessary. | - |
dc.format.extent | 9 | - |
dc.publisher | 한국임상약학회 | - |
dc.title | 국가연구개발과제 생명의학윤리 감독체계에 대한 인식조사 및 제언 | - |
dc.type | Article | - |
dc.identifier.bibliographicCitation | 한국임상약학회지, v.24, no.2, pp 135 - 143 | - |
dc.identifier.kciid | ART001889757 | - |
dc.description.isOpenAccess | N | - |
dc.citation.endPage | 143 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 135 | - |
dc.citation.title | 한국임상약학회지 | - |
dc.citation.volume | 24 | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | national R&D projects | - |
dc.subject.keywordAuthor | perception | - |
dc.subject.keywordAuthor | human subjects & derivatives | - |
dc.subject.keywordAuthor | bioethical oversight | - |
dc.subject.keywordAuthor | IRB | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.